Get 25% discount on our yearly plans! Subscribe now

Key Metrics
Market Cap
Total Shares Outstanding
Book Value
PE Ratio
PS Ratio
PB Ratio
Forward PE Ratio
ROIC
Return on Aseets
Return on Equity
Dividend
Dividend Yield
Balancesheet Metrics
Total Assets
Total Liability
Assets-to-Libability Ratio
Total Current Assets
Total Current Liability
Current Ratio
Quick Ratio
Debt to Equity Ratio
Income Statement Metrics
Net Income
EPS
EBITA
Gross Profit
Gross Profit Margin
Operating Margin
Net Profit Margin
Price Metrics
5 Days MA
10 Days MA
20 Days MA
50 Days MA
200 Days MA
52 Weeks High
52 Weeks low
All Time High
RSI
MACD
Share Stats
Shares Float
Shares Short
% Short
% Insider
% Institutions
News

Profile

Recro Pharma Inc (REPH)

Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It offers its products in the form of oral solid doses, sterile injectables, oral liquids, tablets, topicals, liquid/powder filled capsules, ophthalmic droppers, liposomes, and nano/microparticles, as well as in the areas of aseptic fill/finish, lyophilization, packaging, and logistics services. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.

Exchange: NASDAQ

IPO Date: 3/7/2014

Sector: Healthcare

Industry: Pharmaceuticals

Employees: 0

Address: 1 E. Uwchlan Avenue, Exton, PA, United States, 19341

https://www.recrocdmo.com

&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;Totals
Totals-
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;Totals
Totals-
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;Totals
Totals-
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;Totals
Totals-
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;Totals
Totals-
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;Totals
Totals-